By Debdeep Gupta | 05 Sep, 2025
Zydus Lifesciences shares gain on signing licensing agreement with Synthon
Zydus Lifesciences share price gained in the opening trade on September 5 after the company's wholly owned subsidiary, Zydus Lifesciences Global FZE, has entered into an exclusive licensing and supply agreement with Synthon BV of the Netherlands for Ozanimod Capsules for the US market.At 09:19am, Zydus Lifesciences was quoting at Rs 1,020.00, up Rs 8.00, or 0.79 percent, on the BSE.Synthon has a p...
Live Comments